AllazoHealth
AllazoHealth is a New York-based healthcare analytics company, founded in 2012, that provides individualized intervention targeting to improve medication adherence for pharmaceutical and healthcare clients. It operates as a small private firm (11-50 employees) with minimal disclosed funding.
- Company typePrivate
- Founded2012
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What AllazoHealth does
AllazoHealth is a New York-based, for-profit private company founded in 2012 that provides analytics services designed to improve medication adherence through individualized intervention targeting. The company operates in the healthcare/pharmaceutical software space, with its core product positioned as a patient-level analytics layer that selects the right adherence intervention for the right patient — a category commonly used by pharmaceutical manufacturers, payers, pharmacy benefit managers, and provider organizations seeking to lift script persistence, refill adherence, and outcomes-based contract performance. The firm's go-to-market is implicitly B2B, given its focus on adherence analytics and the company type, though the input does not disclose pricing, contract structure, named customers, or revenue model. The headcount band of 11-50 employees is consistent with a small analytics team rather than a scaled software platform, and the disclosed capital base is minimal — only $20,000 in funding is quantified (Blueprint Health, 2012), with subsequent rounds through 2016 from entities including the New York Digital Health Accelerator (2014) and the Harvard Business School Alumni Angels of Greater NY (2016).
The executive team is compact and function-complete for an early-stage healthcare analytics business: CEO William Grambley, founder/CTO Clifford Jones, CFO Francis Barker, and Chief Customer and Clinical Officer Linda Schultz. This composition implies an intent to bridge technical analytics, finance, and clinical/customer evidence — a structure typical of companies preparing for payer or pharma enterprise procurement, where clinical validation and customer success are gating requirements.
It is important to note that a large portion of the technology, product, and customer-segment detail provided in the input aggregation appears to be sourced from AssistRx's website rather than from AllazoHealth directly; the AssistRx profile (specialty pharmaceutical solutions platform with iAssist, CoAssist, Advanced eServices, and proprietary AI targeting/next-best-action capabilities) is a separate company, and AllazoHealth's own technology stack, product surface, and customer list are not independently disclosed in the available sources. As a result, the analytic picture for AllazoHealth is limited to firmographic, leadership, and funding signals, with no verifiable product, technology, or commercial detail beyond the adherence-analytics positioning.
AllazoHealth firmographics
Firmographics- Name
- AllazoHealth
- Website
- https://allazohealth.com
- Company type
- Private
- Founded year
- 2012
- Headcount range
- 11–50 employees
- Short description
- AllazoHealth is a New York-based healthcare analytics company, founded in 2012, that provides individualized intervention targeting to improve medication adherence for pharmaceutical and healthcare clients. It operates as a small private firm (11-50 employees) with minimal disclosed funding.
- Ownership category
- akta.pro rank
AllazoHealth industry classification
Industry- Product category
- Healthcare Analytics Software
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
- akta.pro secondary industry
- Medication Adherence, Reminders & Patient Support (HLACAKAF)
Keywords
Where AllazoHealth is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
AllazoHealth business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Distribution channels2 records
Marketing channels6 records
AllazoHealth product offering
Product offeringCore offering
AllazoHealth provides analytics services that improve medication adherence through individualized intervention targeting. Leveraging AI, the platform identifies patients at risk of non-adherence and recommends tailored interventions and engagement strategies designed to improve therapy uptake and persistence for healthcare and life sciences organizations.
Differentiator
Problem solved
Functional benefit
Products and services
- Medication Adherence Analytics Platform AllazoHealth's AI-driven analytics platform improves medication adherence by identifying patients at risk of non-adherence and recommending individualized intervention strategies. It is sold to pharmaceutical manufacturers, payers, and healthcare providers to scale targeted adherence support.
Quantifiable outcome
- M+ transactions processed annually
- +2 more outcomes
Companies that use AllazoHealth
Customer profileSegments2 records
Ideal customer profiles2 records
AllazoHealth technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
AllazoHealth partnerships and signals
Strategic signalScale indicators6 records
Recent moves5 records
Expansion highlights3 records
AllazoHealth competitors and assessment
Company assessmentDirect peers
- RxAnte: RxAnte is a medication adherence analytics platform owned by McKesson that uses predictive models to help health plans target interventions for Medicare Star Ratings and adherence measures — a direct competitor in adherence analytics.
- AdhereHealth: AdhereHealth provides medication adherence analytics and outreach services to health plans and PBMs, using predictive analytics to prioritize interventions — directly comparable to AllazoHealth's adherence-targeting analytics model.
Emerging players
- AiCure: AiCure applies AI to patient behavior monitoring and adherence in clinical trials and commercial therapies; comparable as an AI-driven adherence and patient engagement company serving pharma.
- AdhereTech: AdhereTech combines smart connected pill bottles with adherence analytics for pharma and clinical trial clients — a partial-overlap adherence platform with a different primary data-collection modality.
- Medisafe: Medisafe is a digital medication management platform using personalized reminders and AI to improve adherence; overlapping use cases with AllazoHealth though typically more patient-facing than payer-facing.
- HealthPrize Technologies: HealthPrize provides gamified patient engagement and adherence solutions for pharma brands; adjacent to AllazoHealth's adherence-improvement offering but more rewards/engagement-led than predictive-analytics-led.
Broad incumbents
- OptumRx (UnitedHealth Group): OptumRx is one of the largest PBMs in the U.S. and runs internal adherence programs and analytics for its payer clients; a broad incumbent that could build or acquire competing adherence-targeting capabilities.
- Surescripts: Surescripts operates the dominant U.S. e-prescribing network and increasingly offers medication intelligence and adherence-related data services to payers and providers — a broad incumbent in prescription data infrastructure.
- Health Dialog: Health Dialog, part of Rite Aid / Healthmap Solutions, offers adherence and chronic condition management programs for health plans; broader healthcare engagement portfolio but overlapping adherence analytics and outreach value proposition.
- TrialCard (now Mercalis): Mercalis provides patient access, affordability, and adherence solutions for specialty pharma manufacturers at scale; broader portfolio than AllazoHealth but overlapping adherence/patient support value proposition.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
AllazoHealth social profiles
Digital presenceAllazoHealth financial estimates
Financial estimateRevenue estimate
Valuation estimate
AllazoHealth leadership team
Management profileNumber of profiles
Profiles4 records
AllazoHealth funding detail
Funding detailFunding overview
Funding rounds6 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AllazoHealth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AllazoHealth
What does AllazoHealth do?
AllazoHealth provides analytics services that improve medication adherence through individualized intervention targeting. Leveraging AI, the platform identifies patients at risk of non-adherence and recommends tailored interventions and engagement strategies designed to improve therapy uptake and persistence for healthcare and life sciences organizations.
When was AllazoHealth founded?
AllazoHealth was founded in 2012. It employs 11 to 50 people.
Where is AllazoHealth based?
AllazoHealth is headquartered in New York, United States, in the North America region.
Who are AllazoHealth's main competitors?
Direct peers on record are RxAnte and AdhereHealth. Emerging players are AiCure, AdhereTech, Medisafe and HealthPrize Technologies. Broad incumbents are OptumRx (UnitedHealth Group), Surescripts, Health Dialog and TrialCard (now Mercalis).
Does AllazoHealth have an API?
No public API is recorded for AllazoHealth.
What industry is AllazoHealth in?
AllazoHealth's product category is Healthcare Analytics Software. Its primary akta.pro industry code is HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM), with a secondary code of HLACAKAF, Medication Adherence, Reminders & Patient Support. Its NAICS code is 6219 and its SIC code is 7372.